Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jӓnne PA"'
Autor:
Keunchil Park, Eunhye Baek, Yong Kek Pang, Jong Seok Lee, Chong-Jen Yu, Hyun Jin Kim, Enriqueta Felip, Young Su Noh, Ming-Fang Wu, Jin Hyoung Kang, Dong Wan Kim, Byoung Chul Cho, Dae Ho Lee, Ji Youn Han, Pasi A. Jӓnne
Publikováno v:
Scientia
Cancer
Cancer
Background In this open‐label, international phase 2 study, the authors assessed the efficacy and safety of olmutinib in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) who had a confirmed T790M mutation and diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75f0871fab9d4ebe8e46724e04c8e0a
https://hdl.handle.net/11351/6087
https://hdl.handle.net/11351/6087
Autor:
Adib E; Department of Medicine - Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck St, Boston, MA, 02215, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nassar AH; Department of Medicine - Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck St, Boston, MA, 02215, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Abou Alaiwi S; Department of Medicine - Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck St, Boston, MA, 02215, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Groha S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Akl EW; Department of Medicine - Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck St, Boston, MA, 02215, USA., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Michael KS; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Jӓnne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Kwiatkowski DJ; Department of Medicine - Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck St, Boston, MA, 02215, USA. dk@rics.bwh.harvard.edu.
Publikováno v:
Genome medicine [Genome Med] 2022 Apr 15; Vol. 14 (1), pp. 39. Date of Electronic Publication: 2022 Apr 15.
Autor:
Park K; Division of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Jӓnne PA; Lowe Center for Thoracic Oncology, The Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Han JY; National Cancer Center, Goyang, Republic of Korea., Wu MF; Chung Shan Medical University Hospital, Taichung, Taiwan., Lee JS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kang JH; Department of Radiation Oncology, Catholic University of Korea, Seoul St Mary's Hospital, Seoul, Republic of Korea., Lee DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Yu CJ; Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Pang YK; Division of Respiratory Medicine, University of Malaya Medical Center, Kuala Lumpur, Malaysia., Felip E; Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Kim H; Hanmi Pharmaceutical Company, Ltd, Seoul, Republic of Korea., Baek E; Hanmi Pharmaceutical Company, Ltd, Seoul, Republic of Korea., Noh YS; Hanmi Pharmaceutical Company, Ltd, Seoul, Republic of Korea.
Publikováno v:
Cancer [Cancer] 2021 May 01; Vol. 127 (9), pp. 1407-1416. Date of Electronic Publication: 2021 Jan 12.